Research from the University of Michigan suggests that one day a phone app could be able to detect the development of hepatic encephalopathy in patients just by listening to them speak.

Leveraging rapid technological advances for human health is a global trend, driving the rise of biomedical engineering research.

Neuralink announced on social media that it received FDA breakthrough device designation for its vision-restoring Blindsight implant.

GE HealthCare (Nasdaq: GEHC)+
announced today that the FDA has cleared its new imaging tool to assess people with potential Alzheimer’s disease.

Forest Devices announced today that it received FDA 510(k) clearance for its SignalNED Model RE system for brain state analysis.